I wonder what the cumulative effects of performance-enhancing drugs are on GDP. No, not the baseball/A-Rod type, I'm sure that has a relatively small effect, but caffeine and stimulants like Alertec (and maybe coke if you're in the financial industry, reportedly).
What happens to a company's bottom line when it takes away free caffeine? If you have to pay $1 for a Mountain Dew, surely it will have a negative effect on consumption. This must translate to slower employees and less productivity.
Does the money saved by not giving away free caffeine outweight the performance gains by having employees wired all day long? I'm sure you'll have healthier employees in the long run, but I'd bet money that the company's bottom line suffers.
I don't know the answers, just wondering.
